Athyrium Capital Management

Latest statistics and disclosures from Athyrium Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BIOR, PBYI, and represent 100.00% of Athyrium Capital Management's stock portfolio.
  • Reduced shares in these 1 stock: Coherus Biosciences (-$22M).
  • Sold out of its position in Coherus Biosciences.
  • Athyrium Capital Management was a net seller of stock by $-22M.
  • Athyrium Capital Management has $8.7M in assets under management (AUM), dropping by -74.10%.
  • Central Index Key (CIK): 0001728001

Tip: Access up to 7 years of quarterly data

Positions held by Athyrium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Athyrium Capital Management

Athyrium Capital Management holds 2 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Biora Therapeutics Com New (BIOR) 63.1 $5.5M 11M 0.50
 View chart
Puma Biotechnology (PBYI) 36.9 $3.2M 1.3M 2.55
 View chart

Past Filings by Athyrium Capital Management

SEC 13F filings are viewable for Athyrium Capital Management going back to 2017

View all past filings